Cargando…

MET in glioma: signaling pathways and targeted therapies

Gliomas represent the most common type of malignant brain tumor, among which, glioblastoma remains a clinical challenge with limited treatment options and dismal prognosis. It has been shown that the dysregulated receptor tyrosine kinase (RTK, including EGFR, MET, PDGFRα, ect.) signaling pathways ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Fangling, Guo, Dongsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585013/ https://www.ncbi.nlm.nih.gov/pubmed/31221203 http://dx.doi.org/10.1186/s13046-019-1269-x

Ejemplares similares

MET Signaling Pathways, Resistance Mechanisms, and Opportunities for Target Therapies
por: Rivas, Solange, et al.
Publicado: (2022)

Biomarker development in MET-targeted therapy
por: Zhang, Yanni, et al.
Publicado: (2016)

Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways
por: Meng, Xiangqi, et al.
Publicado: (2020)

Role of HGF–MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer
por: Della Corte, Carminia Maria, et al.
Publicado: (2014)

Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells
por: Zhang, Lei, et al.
Publicado: (2018)

Targeting the MET-Signaling Pathway in Non-Small–Cell Lung Cancer: Evidence to Date
por: Bylicki, Olivier, et al.
Publicado: (2020)

The role of HGF/c-MET signaling pathway in lymphoma
por: Lam, Bao Quoc, et al.
Publicado: (2016)

c-Met as a Target for Personalized Therapy
por: Garajová, Ingrid, et al.
Publicado: (2015)

Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
por: Cruickshanks, Nichola, et al.
Publicado: (2017)

Aberrant Signaling Pathways in Glioma
por: Nakada, Mitsutoshi, et al.
Publicado: (2011)

Hippo Signaling Pathway in Gliomas
por: Masliantsev, Konstantin, et al.
Publicado: (2021)

An Observatory for the MET Oncogene: A Guide for Targeted Therapies
por: Altintas, Dogus M., et al.
Publicado: (2023)

The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches
por: Hu, Chi-Tan, et al.
Publicado: (2017)

Targeted Arginine Metabolism Therapy: A Dilemma in Glioma Treatment
por: Hou, Xiaoshuang, et al.
Publicado: (2022)

Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?
por: Ariyawutyakorn, Witthawat, et al.
Publicado: (2016)

MODL-06. Targeting c-MET in combination with radiation is effective in MET-fusion driven high-grade glioma
por: Zuckermann, Marc, et al.
Publicado: (2022)

Targeting MET in cancer therapy
por: Mo, Hong-Nan, et al.
Publicado: (2017)

Signal pathways of melanoma and targeted therapy
por: Guo, Weinan, et al.
Publicado: (2021)

Signaling pathways and targeted therapies for psoriasis
por: Guo, Jia, et al.
Publicado: (2023)

Companion Diagnostics and Predictive Biomarkers for MET-Targeted Therapy in NSCLC
por: Jørgensen, Jan Trøst, et al.
Publicado: (2022)

Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling
por: Lee, Jin-Ku, et al.
Publicado: (2014)

High expression of TXNDC11 indicated unfavorable prognosis of glioma
por: Peng, Peng, et al.
Publicado: (2021)

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer
por: Wang, Qiming, et al.
Publicado: (2019)

Development of antibody-based c-Met inhibitors for targeted cancer therapy
por: Lee, Dongheon, et al.
Publicado: (2015)

Developmentally regulated signaling pathways in glioma invasion
por: Mehta, Shwetal, et al.
Publicado: (2017)

Updated Insights on EGFR Signaling Pathways in Glioma
por: Oprita, Alexandru, et al.
Publicado: (2021)

Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases
por: Whang, Young Mi, et al.
Publicado: (2019)

Targeted therapy in the treatment of malignant gliomas
por: Lukas, Rimas V, et al.
Publicado: (2009)

Signaling pathways and targeted therapy for myocardial infarction
por: Zhang, Qing, et al.
Publicado: (2022)

cGAS-STING pathway targeted therapies and their applications in the treatment of high-grade glioma
por: Tripathi, Shashwat, et al.
Publicado: (2022)

Extracellular Matrix Influencing HGF/c-MET Signaling Pathway: Impact on Cancer Progression
por: Noriega-Guerra, Heydi, et al.
Publicado: (2018)

MET/HGF Signaling Pathway in Ovarian Carcinoma: Clinical Implications and Future Direction
por: Mhawech-Fauceglia, Paulette, et al.
Publicado: (2012)

MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis
por: Liang, Hongge, et al.
Publicado: (2020)

MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature Review
por: Dong, Yiting, et al.
Publicado: (2022)

Glioma targeted therapy: insight into future of molecular approaches
por: Yang, Keyang, et al.
Publicado: (2022)

The Present and Future of Optic Pathway Glioma Therapy
por: Dal Bello, Simone, et al.
Publicado: (2023)

Long non-coding RNA in glioma: signaling pathways
por: Shi, Jia, et al.
Publicado: (2017)

Therapies targeting the signal pathways of pheochromocytoma and paraganglioma
por: Liu, Yalin, et al.
Publicado: (2019)

Immunosuppressive Signaling Pathways as Targeted Cancer Therapies
por: Setlai, Botle Precious, et al.
Publicado: (2022)

Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy
por: Chiriaco, Cristina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v3kl66ttf215q62s783e4e975a